214 ([M +] 65%), 213 (100%); HRMS (C11H9F3O) calcd 214.0605,
found 214.0607.
the R-vinyl carbon and carbonyl oxygen would produce enan-
tiomers 8 of equal energy. It is noteworthy that the iodo analogue
3b(E) could not be isolated by the same procedure used for
3a(E), and carbon-iodine/oxygen-iodine bonds are more
polarizable than those with bromine.
(Z)-4-Phenyl-3-(trifluoromethyl)but-3-en-2-one (5c). 1H NMR
δ 2.48 (s, 3H), 7.41 (m, 5H), 7.88 (s, 1H); 19F NMR δ 57.4 (s,
3F); 13C NMR δ 27.8, 122.1 (q, J ) 274.2 Hz), 128.3, 129.4, 130.1
(q, J ) 28.9 Hz), 130.2, 132.4, 146.8 (q, J ) 3.2 Hz), 194.7; EI-
MS m/z 214 ([M +] 40%), 213 (100%); HRMS (C11H9F3O) calcd
214.0605, found 214.0589.
In conclusion, we have employed (CF3)2Hg/Cu/DMA for
trifluoromethylation of bromo- and iodoalkenes (including
protected 5-iodouracil nucleosides). Higher temperatures are
required than for some methods that use CF3Cu generated from
CuX (X ) Br, I), but a variety of vinyl halides give high yields
in DMA at 140 °C. Reactions with E and Z isomers of several
haloalkenes 3 showed that gem-carbonyl groups can alter cross-
coupling stereochemistry in some cases. Insertion of copper
species into carbon-halogen bonds followed by equilibration
involving copper allenoates 7 might rationalize formation of
products with inverted configurations. Our (CF3)2Hg/Cu/DMA
methodology does not require stainless steel reactors, glove box
techniques, syringe-pump reagent additions, or lengthy reaction
times, and no CF2 insertion byproducts have been observed.
NOTE: caution must be exercised when handling volatile and
toxic organomercury compounds.
Methyl (E)-3-Phenyl-2-(trifluoromethyl)prop-2-enoate12a (4d).
1H NMR δ 3.90 (s, 3H), 7.35-7.42 (m, 6H); 19F NMR δ 64.3 (s,
3F); 13C NMR δ 52.5, 122.1 (q, J ) 273.1 Hz), 123.1 (q, J ) 31.5
Hz), 128.6, 129.1, 130.4, 132.1, 140.4 (q, J ) 5.6 Hz), 163.8; EI-
MS m/z 230 ([M +] 100%); HRMS (C11H9F3O2) calcd 230.0554,
found 230.0562.
Methyl (Z)-3-Phenyl-2-(trifluoromethyl)prop-2-enoate12a (5d).
1H NMR δ 3.77 (s, 3H), 7.37-7.43 (m, 5H), 8.11 (s, 1H); 19F NMR
δ 58.5 (s, 3F); 13C NMR δ 52.4, 121.8 (q, J ) 274.1 Hz), 122.1
(q, J ) 32.0 Hz), 128.1, 129.1, 129.9, 132.3, 148.3, 163.5; EI-MS
m/z 230 ([M +] 100%); HRMS (C11H9F3O2) calcd 230.0554, found
230.0554.
Ethyl (E)-3-(4-Nitrophenyl)-2-(trifluoromethyl)prop-2-enoate12a
1
(4e). H NMR δ 1.21 (t, J ) 7.3 Hz, 3H), 4.23 (q, J ) 7.3 Hz,
2H), 7.51 (s, 1H), 7.55 and 8.26 (2 × d, J ) 8.3 Hz, 2 × 2H); 19
F
NMR δ 64.8 (s, 3F); 13C NMR δ 13.4, 62.2, 121.5 (q, J ) 273.7
Hz), 123.4, 126.6 (q, J ) 31.6 Hz), 129.6, 138.4 (q, J ) 5.6 Hz),
138.8, 148.2, 162.0; EI-MS m/z 289 ([M +] 90%), 244 (100%);
HRMS (C12H10F3NO4) calcd 289.0562, found 289.0569.
Experimental Section29
General Procedure for Trifluoromethylation of Alkenyl
Bromides and Iodides. Freshly generated copper powder18
(341 mg, 5.33 mmol) was dried at 140 °C for 1 h under vacuum in
a 30-mL flask equipped with a Teflon valve. After cooling to
ambient temperature, (CF3)2Hg8,17 (452 mg, 1.33 mmol) and dried
N,N-dimethylacetamide (DMA; 2.0 mL) were added under a
nitrogen atmosphere, and the mixture was stirred at 140 °C for 2
h. [CAUTION: bis(trifluoromethyl)mercury is volatile and toxic
and should be used only by experienced researchers with appropriate
safety precautions.] A solution of the vinyl iodide or bromide (1.33
mmol) in DMA was then added to the dark-green suspension, and
stirring was continued for 2 h at 140 °C. The cooled supernatant
was transferred into a vigorously stirred solution of brine (50 mL),
and the mixture was extracted (EtOAc; 3 × 20 mL). Volatiles were
evaporated from the organic layer, and the residue was chromato-
graphed to give the purified product.
Ethyl (Z)-3-(4-Nitrophenyl)-2-(trifluoromethyl)prop-2-enoate12a
1
(5e). H NMR δ 1.40 (t, J ) 7.3 Hz, 3H), 4.39 (q, J ) 7.3 Hz,
2H), 7.53 and 8.27 (2 × d, J ) 8.3 Hz, 2 × 2H), 8.11 (s, 1H); 19
F
NMR δ 58.4 (s, 3F); 13C NMR δ 13.8, 62.3, 121.3 (q, J )
274.7 Hz), 123.3, 125.6 (q, J ) 32.0 Hz), 129.4, 139.1, 145.1 (q,
J ) 2.3 Hz), 148.1, 162.2; EI-MS m/z 289 ([M +] 90%), 244
(100%); HRMS (C12H10F3NO4) calcd 289.0562, found 289.0574.
2,2,2-Trifluoroethyl (E)-3-(4-Nitrophenyl)-2-(trifluorometh-
yl)prop-2-enoate (4f). 1H NMR δ 4.55 (q, J ) 8.1 Hz, 2H), 7.35-
7.55 (m, 2H), 7.73 (s, 1H), 8.26-8.28 (m, 2H); 19F NMR δ 64.7
(s, 3F), 74.0 (t, J ) 8.5 Hz, 3F); 13C NMR δ 60.9 (q, J ) 37.4
Hz), 121.3 (q, J ) 273.9 Hz), 122.3 (q, J ) 276.9 Hz), 123.6,
124.7 (q, J ) 32.3 Hz), 129.5, 138.4, 142.0 (q, J ) 6.1 Hz), 148.5,
160.4; EI-MS m/z 343 ([M + Na+] 100%); HRMS (C12H7F6NO4)
calcd 343.0279, found 343.0293.
2,2,2-Trifluoroethyl (Z)-3-(4-Nitrophenyl)-2-(trifluoromethyl)-
2′-Deoxy-3-(4-methoxybenzyl)-3′,5′-di-O-(4-methylbenzoyl)-
5-(trifluoromethyl)uridine (2d). H NMR δ 2.23 (ddd, J ) 6.8,
1
1
prop-2-enoate (5f). H NMR δ 4.70 (q, J ) 8.1 Hz, 2H), 7.55-
7.57 (m, 2H), 8.21 (s, 1H), 8.29-8.31 (m, 2H); 19F NMR δ 58.6
(s, 3F), 74.2 (t, J ) 8.5 Hz, 3F); EI-MS m/z 343 ([M + Na+] 100%);
13C NMR δ 61.5 (q, J ) 32.8 Hz), 120.9 (q, J ) 275.2 Hz), 121.7
(q, J ) 277.2 Hz), 123.6, 124.2 (q, J ) 32.3 Hz), 129.7, 138.3,
147.4, 148.5, 160.8; HRMS (C12H7F6NO4) calcd 343.0279, found
343.0280.
7.8, 14.2 Hz, 1H), 2.39 (s, 3H), 2.44 (s, 3H), 2.87 (ddd, J ) 1.0,
5.4, 14.2 Hz, 1H), 3.78 (s, 3H), 4.59-4.61 (m, 1H), 4.67-4.75
(m, 2H), 5.00 (d, J ) 13.7 Hz, 1H), 5.06 (d, J ) 13.7 Hz, 1H),
5.59 (d, J ) 6.3 Hz, 1H), 6.33 (dd, J ) 5.4, 8.3 Hz, 1H), 6.82-
7.94 (m, 12H), 8.05 (s, 1H); 19F NMR δ 64.3 (s, 3F); 13C NMR δ
21.3, 21.4, 38.8, 43.7, 54.8, 63.7, 68.7, 74.7, 83.0, 87.0, 104.4 (q,
J ) 32.8 Hz), 113.5, 121.7 (q, J ) 270.2 Hz), 126.0, 127.8, 129.0-
130.8 (ovlp), 137.8 (q, J ) 5.0 Hz), 144.2, 144.3, 149.5, 157.6,
159.1, 165.6, 165.7; FAB-MS m/z 675 ([M + Na+] 100%); HRMS
(C34H31F3N2O8Na) calcd 675.1924, found 675.1923.
Acknowledgment. We gratefully acknowledge NIH grant
GM029332, pharmaceutical company unrestricted gift funds
(M.J.R.), and Brigham Young University for support of this
research and Professor Steven R. Herron for determining the
X-ray crystal structure of 3g(2E,4Z).
(E)-4-Phenyl-3-(trifluoromethyl)but-3-en-2-one (4c). 1H NMR
δ 2.21 (s, 3H), 7.30-7.44 (m, 6H); 19F NMR δ 63.9 (s, 3F); 13C
NMR δ 30.7, 122.1 (q, J ) 274.2 Hz), 128.7, 129.0, 130.3, 131.3
(q, J ) 29.1 Hz), 132.1, 137.0 (q, J ) 6.1 Hz), 198.8; EI-MS m/z
Supporting Information Available: Experimental procedures,
data, X-ray crystal structure of 3g(2E,4Z) in CIF format, and NMR
spectra. This material is available free of charge via the Internet at
(29) See Supporting Information for general experimental details,
preparation of starting materials, and other trifluoromethyl compounds, data,
and spectra.
JO062544A
J. Org. Chem, Vol. 72, No. 7, 2007 2681